Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;29(5):537-43.
doi: 10.1097/MOG.0b013e328363affe.

Deciphering the role of stroma in pancreatic cancer

Meghna Waghray  1 , Malica Yalamanchili, Marina Pasca di Magliano, Diane M Simeone
Affiliations
Review

Deciphering the role of stroma in pancreatic cancer

Meghna Waghray et al. Curr Opin Gastroenterol. 2013 Sep.

Abstract

Purpose of review: This review intends to describe recent studies on pancreatic tumor-associated stroma and potential opportunities and limitations to its targeting.

Recent findings: One of the defining features of pancreatic cancer is extensive desmoplasia, or an inflammatory, fibrotic reaction. Carcinoma cells live in this complex microenvironment which is comprised of extracellular matrix (ECM), diffusible growth factors, cytokines and a variety of nonepithelial cell types including endothelial cells, immune cells, fibroblasts, myofibroblasts and stellate cells. In addition to the heterogeneity noted in the nonneoplastic cells within the tumor microenvironment, it has also been recognized that neoplastic cancer cells themselves are heterogeneous, and include a subpopulation of stem-cell like cells within tumors termed cancer stem cells. Due to the failure of current therapeutics to improve outcomes in patients with pancreatic cancer, new therapeutic avenues targeting different components of the tumor microenvironment are being investigated. In this review article, we will focus on recent studies regarding the function of the tumor stroma in pancreatic cancer and therapeutic treatments that are being advanced to target the stroma as a critical part of tumor management.

Summary: Recent studies have shed new light on the contribution of the pancreatic cancer fibroinflammatory stroma to pancreatic cancer biology. Additional studies are needed to better define its full contribution to tumor behavior and how to best understand the optimal ways to develop therapies that counteract its pro-neoplastic properties.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Model of tumor-stromal interactions: Kras induced Hedgehog signaling promotes the early steps of tumor development leading to the characteristic unyielding pancreatic desmoplastic reaction
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008 Mar-Apr;58(2):71–96. - PubMed
    1. [accessed May 2013]; http:/seer.cancer.gov/statfacts/html/pancreas.html.
    1. Drug Combo Effective against Pancreatic Cancer. Cancer Discov. 2013 Apr;3(4):OF8. - PubMed
    1. Gunturu KS, Yao X, Cong X, Thumar JR, Hochster HS, Stein SM, et al. FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity. Med Oncol. 2013 Mar;30(1):361. - PubMed
    1. Von Hoff DD, Ramanathan RK, Borad MJ, Laheru DA, Smith LS, Wood TE, et al. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol. 2011 Dec 1;29(34):4548–54. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources